Effects of Heart Rate Reduction on Central Arterial Pressure in Healthy Individuals

PHASE4TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

November 8, 2011

Study Completion Date

November 8, 2011

Conditions
Central Arterial Pressure
Interventions
DRUG

Ivabradine

Ivabradine 10 mg once

DRUG

Metoprolol

Metoprolol 50 mg once

DRUG

Placebo

Lactose powder

Trial Locations (1)

3004

The Alfred Hospital, Melbourne

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Baker Heart and Diabetes Institute

OTHER

lead

Bayside Health

OTHER_GOV